Enovis Co. (NYSE:ENOV) Shares Acquired by Southeastern Asset Management Inc. TN

Southeastern Asset Management Inc. TN grew its stake in Enovis Co. (NYSE:ENOV - Free Report) by 60.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 36,583 shares of the company's stock after purchasing an additional 13,797 shares during the quarter. Southeastern Asset Management Inc. TN owned approximately 0.06% of Enovis worth $1,605,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of ENOV. Aster Capital Management DIFC Ltd acquired a new stake in shares of Enovis in the fourth quarter valued at about $29,000. Quadrant Capital Group LLC grew its position in shares of Enovis by 53.0% in the fourth quarter. Quadrant Capital Group LLC now owns 690 shares of the company's stock valued at $30,000 after purchasing an additional 239 shares during the period. UMB Bank n.a. grew its position in shares of Enovis by 128.2% in the fourth quarter. UMB Bank n.a. now owns 778 shares of the company's stock valued at $34,000 after purchasing an additional 437 shares during the period. Pinnacle Bancorp Inc. grew its position in shares of Enovis by 54.5% in the fourth quarter. Pinnacle Bancorp Inc. now owns 850 shares of the company's stock valued at $37,000 after purchasing an additional 300 shares during the period. Finally, Quarry LP grew its position in shares of Enovis by 506.1% in the fourth quarter. Quarry LP now owns 897 shares of the company's stock valued at $39,000 after purchasing an additional 749 shares during the period. Institutional investors and hedge funds own 98.45% of the company's stock.

Enovis Stock Performance

NYSE:ENOV opened at $35.86 on Friday. The company's 50-day moving average price is $35.16 and its 200-day moving average price is $41.45. The company has a current ratio of 2.27, a quick ratio of 1.12 and a debt-to-equity ratio of 0.40. The company has a market cap of $2.05 billion, a P/E ratio of -16.37 and a beta of 1.79. Enovis Co. has a twelve month low of $29.32 and a twelve month high of $53.31.

Enovis (NYSE:ENOV - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The company reported $0.81 earnings per share for the quarter, topping the consensus estimate of $0.74 by $0.07. The firm had revenue of $558.83 million for the quarter, compared to the consensus estimate of $558.80 million. Enovis had a negative net margin of 5.95% and a positive return on equity of 4.39%. The company's revenue for the quarter was up 8.2% on a year-over-year basis. During the same period last year, the firm posted $0.50 earnings per share. On average, sell-side analysts forecast that Enovis Co. will post 2.79 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

ENOV has been the topic of several research analyst reports. JMP Securities dropped their target price on shares of Enovis from $62.00 to $55.00 and set a "market outperform" rating on the stock in a research report on Friday, May 9th. Canaccord Genuity Group dropped their target price on shares of Enovis from $75.00 to $70.00 and set a "buy" rating on the stock in a research report on Wednesday. Finally, Needham & Company LLC decreased their price target on shares of Enovis from $64.00 to $57.00 and set a "buy" rating on the stock in a research note on Friday, May 9th. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $58.00.

Enovis Profile

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.